NCT04701580View on ClinicalTrials.gov

Synaptic Density and Progression of Huntington's Disease.

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Huntington Disease
Interventions
DIAGNOSTIC_TEST

11C-UCB-J PET-CT

Positron Emission Tomography (PET) of synaptic vesicle protein 2A (SV2A) using the radioligand 11C-UCB-J.

DIAGNOSTIC_TEST

18F-FDG PET-MR

Positron Emission Tomography (PET) of glucose metabolism using the radioligand 18F-FDG, and brain MRI performed simultaneously.

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04701580 - Synaptic Density and Progression of Huntington's Disease. | Biotech Hunter | Biotech Hunter